Clinic @ W&C
weight management
Eligibility & Plans
Here you’ll find everything you need to know about who our weight management service is suitable for, what’s included in your monthly plan, and how much it costs.
All treatments are subject to a professional consultation to ensure they’re right for you — but this page gives you a clear overview of what to expect before you get started.
Jump To…
Eligibility
We can provide our Weight Management service to any of the following patients:
- Aged 18 to 75 years, with a BMI of 30 kg/m² or above
or
- Aged 18 to 75 years, with a BMI between 27 and 30 kg/m² who also have one or more of the following conditions:
- Prediabetes or type 2 diabetes
- High blood pressure
- High cholesterol
- Obstructive sleep apnoea
We’ll review all these details during your free initial appointment with one of our trained and registered Pharmacists or Technicians. We’ll also check for any contraindications to ensure your treatment is safe and effective.
During the Consultation
In your free initial consultation, which usually takes 20-30 minutes, our trained and registered Pharmacist or Technician will:
You’ll have plenty of time to ask questions, and there’s no pressure or commitment.
What’s Included?
Our comprehensive weight management service offers everything you need to lose weight, with proven results. You’ll only need to pay if you’re eligible for one of our plans.
Pricing & Plans
You may be eligible for treatment after a consultation with our Pharmacists and Technicians. During your free initial consultation, we’ll discuss all our plans in detail, alongside everything else you need to know whilst taking weight loss medication.
Injectable Plans
Our most popular treatments, achieving the best results for our patients. Our personalised plans are some of the most competitive around.
Wegovy® (Semaglutide)
Prices correct as of 17th November 2025. Prices are subject to periodic change.
Our pricing depends on the strength of the medication supplied, decided by our clinical teams. Patients eligible will be initiated on a 0.25mg dose and titrated up based on tolerability and clinical indications.
Prices correct as of 9th September 2025, these can be subject to short-notice change. Please call if you’d like to check ahead.
Pricing is subject to periodic review and changes to reflect changes in the cost of service delivery, inflation, and profitability. Please call us if you’d like to confirm current prices.
Wegovy® is a prescription-only treatment that helps with weight management. It contains semaglutide, a medicine that works like a natural hormone in the body (GLP-1). It helps to reduce appetite, slow stomach emptying, and increase feelings of fullness, so you eat less. When combined with a healthy diet and regular activity, Wegovy® can support significant and sustained weight loss.
It is indicated for weight management, including weight loss and weight maintenance, for people with a BMI of 30 or over, or a BMI of 27 and over with certain health conditions. This is in addition to reducing calorie intake, and increasing physical activity levels.
In studies lasting 68 weeks, people taking Wegovy® alongside healthy eating and regular activity lost on average 14.9% of their body weight, compared with 2.4% for those not taking the medicine.1
- Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002.
Mounjaro® (Tirzepatide)
Prices correct as of 17th November 2025, these can be subject to change.
Our pricing depends on the strength of the medication supplied, decided by our clinical teams. Patients eligible will be initiated on a 2.5mg dose and titrated up based on tolerability and clinical indications.
Prices correct as of 9th September 2025, these can be subject to short-notice change. Please call if you’d like to check ahead.
Pricing is subject to periodic review and updates to reflect changes in the cost of service delivery, inflation, and profitability. Please call us if you’d like to confirm current prices.
Mounjaro is a medication that can be taken weekly, by injection, to help you lose weight. It can help by reducing feelings of hunger, whilst increasing how full you feel by slowing down how quickly food leaves your stomach (this lessens over time). It also regulates fat utilisation in your body.
It is indicated for weight management, including weight loss and weight maintenance, for people with a BMI of 30 or over, or a BMI of 27 and over with certain health conditions. This is in addition to reducing calorie intake, and increasing physical activity levels.
Trials data showed that users could lose up to 20% of their body weight.2 In any consultation with us, we’ll always discuss the benefits, and any associated risks of treatment, and answer any questions, to help you make an informed choice.
- Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A; SURMOUNT-1 Investigators. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022 Jul 21;387(3):205-216. doi: 10.1056/NEJMoa2206038.
Oral Weight Loss Medications
Affordable treatment, which is taken orally making it easily portable, helping busy lives achieve weight loss.
Orlistat
Prices correct as of 17th November 2025. Prices are subject to periodic change.
Orlistat is indicated for the management of obesity (weight loss and weight maintenance) in overweight or obese adults. Orlistat is an orally active, reversible inhibitor of gastric and pancreatic lipases, reducing the absorption of fats from your diet.
Clinical studies show users on average lost 2.9% more weight compared with placebo. 21% of users achieved ≥5% weight loss, and 12% of users achieved ≥10% of weight loss.3
It’s taken by mouth, up to three times each day alongside main meals to help reduce fat absorption and aid weight loss.
- Padwal R, Li SK, Lau DC. Long-term pharmacotherapy for obesity and overweight. Cochrane Database Syst Rev. 2004;2003(3):CD004094. doi: 10.1002/14651858.CD004094.pub2.
Mysimba® (Naltrexone/Bupropion)
Prices correct as of 17th November 2025. Prices are subject to periodic change.
Mysimba® is used alongside a reduced-calorie diet and increased physical activity for the management of weight in adults who are obese (BMI >30 kg/m2) or overweight (BMI 27-30 kg/m2) with at least one weight-related complication.
It helps to reduce food cravings and eating related behaviours. In three of the main studies, the average weight loss for patients treated with Mysimba was around 3.7% to 5.7%, compared with 1.3% to 1.9% for those taking a placebo.4
Users who completed treatment lost an average of 11.3 kg vs 7.3 kg for placebo at 56 weeks.5
- Apovian CM, Aronne L, Rubino D, Still C, Wyatt H, Burns C, Kim D, Dunayevich E; COR-II Study Group. A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II). Obesity (Silver Spring). 2013 May;21(5):935-43. doi: 10.1002/oby.20309.
- Wadden TA, Foreyt JP, Foster GD, et al. Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. Obesity (Silver Spring). 2011;19(1):110-120. doi:10.1038/oby.2010.147
Book with us today.
Ashington Pharmacy
Wellway Pharmacy Morpeth
Wellway Pharmacy Pegswood
Register your interest for our upcoming locations.
